Misoprostol--Is More Research Needed?

Moore, Mary Lou
September 2002
Journal of Perinatal Education;2002, Vol. 11 Issue 3, p43
Academic Journal
Discusses the uses of synthetic prostaglandin E1 misoprostol for obstetrics in the U.S. Administration of the prostaglandin for induction of first and second trimester abortion and the control postpartum hemorrhage; Advantages and disadvantages of the uses; Stand of the Food and Drug Administration on the uses of misoprostol.


Related Articles

  • ORAL VERSUS VAGINAL ADMINISTRATION OF MISOPROSTOL FOR LABOR INDUCTION. Bower, Douglas J.; Meurer, Linda N. // Journal of Family Practice;Jan1999, Vol. 48 Issue 1, p9 

    The article discusses research being done on the safety and effectiveness of misoprostol for labor induction. It references a study by K.A. Bennett et al published in a 1998 issue of "Obstetrics & Gynecology." There is an increasing body of evidence that misoprostol, a synthetic prostaglandin E...

  • Name that drug. King, Phil // Drug Topics;10/23/95, Vol. 139 Issue 20, p50 

    Presents a cartoon puzzle on Cytotec (misoprostol).

  • Misoprostol cotherapy reduces ulcer frequency in NSAID users.  // Geriatrics;Nov93, Vol. 48 Issue 11, p28 

    Reports on the benefits of the misoprostol therapy on nonsteroidal anti-inflammatory drug users. Reduction of the risk of developing complications from ulcer in patients receiving prostaglandin E1 analog misoprostol; Potential use for warfarin users.

  • Latanoprost offers neuroprotection beyond lower IOP. Guttman, Cheryl; Drago, Filippo // Ophthalmology Times;04/01/2000, Vol. 25 Issue 7, p23 

    Focuses on the study of Filippo Drago, director of the department of experimental and clinical pharmacology at the University of Catania, Italy, regarding the neuroprotective effects of the synthetic prostaglandin analogue latanoprost. Results of the in vitro experiments; Neuroprotective...

  • Deaths from Clostridium sordellii after Medical Abortion. Baulieu, Etienne-Emile // New England Journal of Medicine;4/13/2006, Vol. 354 Issue 15, p1645 

    A letter to the editor is presented in response to the article "Early Pregnancy Interruption With RU 486 (mifepristone) and Misoprostol, an Orally Active Prostaglandin Analogue" in a previous issue.

  • Methotrexate and misoprostol for early pregnancy termination.  // American Family Physician;1/1/1996, Vol. 53 Issue 1, p350 

    Discusses the article `Methotrexate and misoprostol to terminate early pregnancy,' by R. Hausknecht, published in `New England Journal of Medicine.' Therapeutic uses of methotrexate and misoprostol; Side effects.

  • Menometrorrhagia in patient on Cytotec. R.M.D. // Cortlandt Forum;1/25/95, Vol. 8 Issue 1, p72 

    Presents suggestions to a question about treating a patient with misoprostol Cytotec but develops menometrorrhagia. Indication for Cytotec; Use of sucralfate Carafate.

  • Low-dose latanoprost fares well in Brazilian study. Charters, Linda; Susanna Jr., Remo // Ophthalmology Times;10/01/2000, Vol. 25 Issue 19, p92 

    Evaluates Latanoprost, a prostaglandin analogue used to lower intraocular pressure (IOP). Results of a study comparing latanoprost and unoprostone; Adverse effects; Percentage of IOP that can be reduce by the drug.

  • Bimatoprost.  // Reactions Weekly;2/19/2011, Issue 1339, p12 

    The article describes the case of a 16-year-old girl who developed serous retinal detachment while undergoing bimatoprost treatment.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics